Source: International Congress 2017 – ME9 Boosting immunotherapy in lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
J. Cadranel (Paris, France). Boosting immunotherapy in lung cancer . International Congress 2017 – ME9 Boosting immunotherapy in lung cancer

Member's Comments

No comment yet.

Related content which might interest you: ME9 Boosting immunotherapy in lung cancer Source: Milan 2017 - Educational material Year: 2017 Re-challenge of immunotherapy in a lung cancer patient Source: Virtual Congress 2021 – Lung cancer grand round Year: 2021 Lung cancer immunotherapy Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance! Year: 2018 Immunotherapies for lung cancer Source: International Congress 2018 – ME12 Immunotherapies for lung cancer FULLY BOOKED Year: 2018 Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm Source: Eur Respir J, 55 (2) 1901907; 10.1183/13993003.01907-2019 Year: 2020 Eosinophilia in lung cancer patients treated with immunotherapy Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Ras peptide-specific vaccination in patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2006 - Lung cancer treatment Year: 2006 Impact of antibiotics on immunotherapy response in lung cancer patients Source: International Congress 2019 – Treatment of lung cancer Year: 2019 CAR T-cell therapy for lung cancer Source: International Congress 2017 – A novel approach to lung cancer Year: 2017 Radiation therapy for augmenting the efficacy of immunotherapy in advanced non-small cell lung cancer: a case-controlled study Source: ERJ Open Res, 6 (1) 00189-2019; 10.1183/23120541.00189-2019 Year: 2020 Targeted therapy for lung cancer Source: Eur Respir J 2015; 46: 1239-1241 Year: 2015 How to evaluate the immune status of lung cancer patients before immunotherapy Source: Breathe, 13 (4) 291; 10.1183/20734735.001917 Year: 2017 ME12 Immunotherapies for lung cancer Source: Paris 2018 - Educational material Year: 2018 Influenza and Pneumococcal vaccination effects on the immune-related adverse events in patients under immunotherapy for an advanced stage non-small cell lung cancer Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Response to Immunotherapy in non-small cell lung cancer: the effect of weight Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Targeted therapy in non-small cell lung cancer Source: Breathe 2012; 8: 206-215 Year: 2012 Current place and future of immunotherapy in lung cancer Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies? Year: 2016 Venothromboembolism in lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 601s Year: 2007